Corcept Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CORT and other ETFs, options, and stocks.

About CORT

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. 

CEO
Joseph K. Belanoff
CEOJoseph K. Belanoff
Employees
500
Employees500
Headquarters
Redwood City, California
HeadquartersRedwood City, California
Founded
1998
Founded1998
Employees
500
Employees500

CORT Key Statistics

Market cap
7.52B
Market cap7.52B
Price-Earnings ratio
61.88
Price-Earnings ratio61.88
Dividend yield
Dividend yield
Average volume
693.21K
Average volume693.21K
High today
$71.99
High today$71.99
Low today
$69.03
Low today$69.03
Open price
$69.25
Open price$69.25
Volume
937.14K
Volume937.14K
52 Week high
$117.33
52 Week high$117.33
52 Week low
$37.82
52 Week low$37.82

CORT News

Simply Wall St 1d
The Bull Case For Corcept Therapeutics Could Change Following FDA Acceptance of Relacorilant Application – Learn Why

Corcept Therapeutics recently announced that the FDA has accepted its New Drug Application for relacorilant as a potential treatment for patients with platinum-...

The Bull Case For Corcept Therapeutics Could Change Following FDA Acceptance of Relacorilant Application – Learn Why
TipRanks 7d
Corcept Therapeutics price target raised to $140 from $137 at Canaccord

Canaccord raised the firm’s price target on Corcept Therapeutics (CORT) to $140 from $137 and keeps a Buy rating on the shares. The firm met with management and...

TipRanks 7d
Corcept Therapeutics’ New Drug Application Accepted by FDA

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

People also own

Based on the portfolios of people who own CORT. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.